Penbrook Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Hold
1,700
0.14% 90
2026
Q1
$204K Buy
+1,700
New +$196K 0.15% 84
2025
Q1
Sell
-2,706
Closed -$269K 110
2024
Q4
$269K Sell
2,706
-1,500
-36% -$155K 0.18% 87
2024
Q3
$478K Buy
4,206
+100
+2% +$11.9K 0.31% 64
2024
Q2
$508K Hold
4,106
0.31% 63
2024
Q1
$542K Buy
4,106
+500
+14% +$61.6K 0.34% 67
2023
Q4
$393K Hold
3,606
0.26% 74
2023
Q3
$371K Sell
3,606
-600
-14% -$64.7K 0.27% 75
2023
Q2
$485K Hold
4,206
0.35% 68
2023
Q1
$447K Hold
4,206
0.34% 68
2022
Q4
$467K Sell
4,206
-500
-11% -$51.1K 0.4% 67
2022
Q3
$405K Buy
4,706
+406
+9% +$36.2K 0.35% 71
2022
Q2
$392K Hold
4,300
0.31% 76
2022
Q1
$353K Buy
+4,300
New +$339K 0.23% 85

Other funds holding MRK

Penbrook Management's MRK Position: Q2 2026 in Review

Penbrook Management held its Merck (MRK) position steady in Q2 2026 at 1,700 shares worth $218K. The position accounts for 0.14% of the portfolio, ranked #90.

Penbrook Management first reported a position in MRK in Q1 2022 and has held it in 14 quarters since. The position peaked at $542K in Q1 2024. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Penbrook Management held 1,700 shares of Merck worth $218K as of Q2 2026.
  • Penbrook Management left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.14% of Penbrook Management's portfolio in Q2 2026, its #90 holding.
  • Penbrook Management first reported a position in Merck in Q1 2022 and has held it in 14 quarters since.
  • Penbrook Management's Merck position peaked at $542K in Q1 2024.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Penbrook Management's 13F filing for Q2 2026, filed 23 Jul 2026.